Dear Colleagues,
On behalf of the Organizing Committee and the International Working Group
on Preimplantation Genetics, we would like to invite you to participate
in the Fifth International Symposium on Preimplantation Genetics, which
will be held in Antalya, Turkey, 5-7 June, 2003. It will come only one year
after the previous one held in Cyprus, because of expanding indications
and a wide clinical application of preimplantation genetic diagnosis (PGD).
In contrast to prenatal diagnosis, PGD is being applied also for conditions
with genetic predisposition, and has already become an important component
of Assisted Reproduction. In view of the growing practical importance of
PGD, the Fifth International Symposium on Preimplantation Genetics will
concentrate on the clinical experience of PGD for single gene disorders,
chromosomal anomalies, late onset disorders with genetic predisposition,
sex selection, and non-disease testing. In addition, the relevant developments
in the genome profile analysis and the prospects of therapeutic cloning
will be also addressed. As some of the current applications of PGD are still
controversial, ethical and social issues in connection with PGD and cloning
will be further reviewed.For the second time Symposium is organized in the
Eastern Mediterranean area, where PGD has appeared to be an acceptable option
for prevention of genetic and chromosomal disorders, allowing avoidance
of prenatal diagnosis and termination of pregnancy. Being part of Europe
as well as of Asia, Turkey represents an ideal venue for the Symposium,
allowing an easy access from Europe, Middle East and South East Asia. Antalya
is also a well-known resort in the region, particularly delightful in early
Summer.
We are looking forward to welcoming
you in Antalya, Turkey.
|
Yury Verlinsky Ph.D.
Chairman of International Working Group on Preimplantation Genetics
|
Semra Kahraman MD.
Chairman of Local Organizing and
Scientific Committee
|
The International Advisory Committee & Faculty
Muhterem Bahçe,
Gulhane Military Medical Academy, Ankara, Turkey |
 |
Moncef Benkhalifa,
Advanced Technologies Laboratory, Paris, France |
 |
| Peter Braude,
Guy’s and St. Thomas’s Hospital, London, UK |
 |
Jeanine Cieslak,
Reproductive Genetics Institute, Chicago, USA |
 |
| Jacques Cohen,
St. Barnabas Medical Center, Livingston, USA |
 |
| David Cram,
Monash University, Melbourne, Australia |
 |
| Robert Edwards,
Reproductive BioMedicine Online, Cambridge, UK |
 |
Ursula Eichenlaub-Ritter,
University of Bielefeld, Bielefeld, Germany |
 |
Dov Feldberg,
Rabin Campus Hospital, Petach Tikva, Israel |
 |
Malcolm Ferguson-Smith,
University of Cambridge, Cambridge, UK |
 |
Rene Frydman,
Beclere Hospital, Clamart, France |
 |
| Luca Gianaroli,
SISMER, Center of Reproductive Medicine, Bologna, Italy |
 |
Alan Handyside,
Centre for Reproduction, Growth & Development, Leeds, UK |
 |
Joice Harper,
University College London, London, UK |
 |
| Mark Hughes,
Hutzel Hospital, Detroit, USA |
 |
| Semra Kahraman,
Istanbul Memorial Hospital, Istanbul, Turkey |
 |
| Anver Kuliev,
WHO Collaborating Center for Prevention of Genetics Disorder, Chicago,
USA |
 |
| Inge Liebaers,
Center for Medical Genetics, Brussels, Belgium |
 |
Henry Malter,
St. Barnabas Medical Center, Livingston, USA |
 |
Rene Martin,
Alberta Children's Hospital, Calgary, Canada |
 |
| Marilyn Monk,
Moleculer Embryology Unit, Institute of Child Health,London, UK |
 |
| Santiago Munne,
St. Barnabas Medical Center, Livingston, USA |
 |
| Svetlana Rechitsky,
Reproductive Genetics Institute, Chicago, USA |
 |
Benjamin Reubinoff,
Hadassah University Hospital, Jerusalem, Israel |
 |
| Karen Sermon
Center for Medical Genetics, Brussels, Belgium |
 |
Sherman Silber,
Infertility Center of St.Louis, St Louis, USA |
 |
| Joe Leigh Simpson,
Baylor College of Medicine, Houston, USA |
 |
| Alan Trounson,
Monash University, Melbourne, Australia |
 |
| Nick Strelchenko,
Reproductive Genetics Institute, Chicago, USA |
 |
Alan Trounson,
Monash University, Melbourn, Australia |
 |
Jonatan Van Blerkom,
University of Colorado, Denver, USA |
 |
| Yury Verlinsky,
Reproductive Genetics Institute, Chicago, USA |
 |
| Steen Willadsen,
St. Barnabas Medical Center, Livingston, USA |
Local Organizing & Scientific Committee
|
Assoc. Prof. Semra Kahraman,
Istanbul Memorial Hospital, Istanbul , (Chairman)
|
 |
|
Assoc. Prof. Muhterem Bahçe,
Gülhane Military Medical Academy, Ankara
|
 |
|
Prof. Timur Gürgan,
Hacettepe University, Ankara
|
 |
|
Prof. Ergül Tuncbilek,
Hacettepe University, Ankara
|
 |
|
Moncef Benkhalifa, Ph.D.
Istanbul Memorial Hospital and ATL R&D Lab., Paris
|
 |
|
Prof. Duran Canatan,
Süleyman Demirel University, Isparta
|
 |
|
Prof. Nazli Basak,
Bogazici University, Istanbul
|
 |
|
Prof. Bülent Zülfikar,
Istanbul University, Istanbul
|
 |
Assoc. Prof. Duru Manyali,
TADAD Turkish Thalassemia Society, Istanbul |
 |
Turkish Ministry of Health,
Mother and Child Health/ Family Planning General Directoriate, Ankara |
Preliminary Scientific Program
| SESSION 1. |
Preimplantation Genetic Diagnosis (PGD) Impact
on IVF Efficiency |
| SESSION 2. |
Reproductive Outcome of PGD for Chromosomal Abnormalities |
| SESSION 3. |
PGD for Genetic Predisposition & Preimplantation
Non-disease Testing |
| SESSION 4. |
Application of Microchip Technology & Other Developments
in Genetic Analysis of Single Cells |
| SESSION 5. |
Feasibility of Preimplantation Testing for Genetic Expression
Disorders & Cytoplasmic Abnormalities |
| SESSION 6. |
Stem Cells & Therapeutic Cloning |
| SESSION 7. |
Ethical and Social Aspects of PGD & Therapeutic Cloning
|
Registration, Transportation
& Hotel Accomodation
Before April, 2003
- $320
After that date
- $410
Alabanda Tourism Co. Inc.
Tel: +90 (312) 440 56 00
Fax: +90 (312) 439 59 35
E-mail: info@pgdturkey.org
Abstracts
Deadline: March
31, 2003
Istanbul Memorial Hospital, ART and Genetics Center
Address: Piyale Paşa Bulvarı, 80270, Okmeydanı, Şişli
İstanbul, TURKEYTel: +90 (212) 210 66 66 / 1910-1915
Fax: +90 (212) 210 71 40
E-mail: info@pgdturkey.org
web: http://www.pgdturkey.org/
Abstracts should be submitted via e-mail as a Microsoft Word document
attachment to Istanbul Memorial Hospital at (info@pgdturkey.org) with
name, mailing and e-mail addresses and fax of presenting author, who may
be the first author only once. The entire abstract, including title, author,
institution and country, should not exceed one single-spaced page in the
following format: Objective, Material/Methods, Results and Conclusions.
Abstract must not include any figure, references or tables. If absolutely
essential, tables of simple design may be accepted.
|